Venrock Associates VII L.P. 13D/13G Filings for CYTEIR THERAPEUTICS INC (CYTT)

Venrock Associates VII L.P. 13D and 13G filings for CYTEIR THERAPEUTICS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
4:11 pm
Purchase
2021-12-31 13G CYTEIR THERAPEUTICS INC
CYTT
Venrock Associates VII L.P. 3,259,022
9.200%
3,259,022increase
(New Position)
Filing